KitchenerDDavidsonCBundredP. Integrated care pathways: effective tools for continuous evaluation of clinical practice. Journal of Evaluation in Clinical Practice1996; 2: 65–69
2.
JohnsonS. Factors influencing the success of ICP projects. Professional Nurse2000; 15: 776–779
3.
JohnsonS. What's in a name?Journal of Integrated Care Pathways2001; 5: 111–112
4.
CannonC. Multimodality reperfusion therapy for acute myocardial infarction. American Heart Journal2000; 140: 707–16
5.
CampbellHHotchkissRBradshawNPorteousM. Integrated care pathways. BMJ1998; 316: 133–137
6.
CurrieL. Researching care pathway development in the United Kingdom: Stage 1. Nursing Times Research1999; 4: 378–384
7.
JohnsonSBurrallB. Pathway to the heart. Nursing Management1996; 3: 24–25
8.
SmithDGowP. Towards excellence in quality patient care: A clinical pathway for acute myocardial infarction. Journal of Quality in Clinical Practice1999; 19: 103–105
9.
CannonPJohnsonECermignaniMSciricaBSagarinMWallsR. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction. Clinical Cardiology1999; 22: 17–20
10.
KlennerS. Mapping out a clinical pathway. Registered Nurse2000; 63: 33–36
11.
McKinseyKBorenDFidellowJ. Navigate a clinical pathway for uncomplicated MI patients. Nursing Management1999; 30: 33–35
12.
Clinical Quality Improvement Network Investigators. Influence of a critical path management tool in the treatment of acute myocardial infarction. American Journal of Managed Care1998; 4: 1243–51
13.
HolmboeEMeehanTRadfordMWangYMarciniakTKrumholzH. Use of critical pathways to improve the care of patients with acute myocardial infarction. The American Journal of Medicine1999; 107: 324–331
14.
PearsonS. Et tu, critical pathways?The American Journal of Medicine1999; 107: 397–398
15.
Department of Health. National Service Framework for Coronary Heart Disease.London: HMSO, 2000
16.
Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet1994; 343: 311–322
17.
ISIS-2 (Second International Study of Infarct Survival Collaborative Group). Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet1988; ii: 349–360
18.
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet1994; 334: 1383–1389
19.
ISIS-1 (First International Study of Infarct Survival Collaborative Group). Mechanism for the early mortality reduction produced by beta-blockade early after acute myocardial infarction. Lancet1988; i: 921–923
20.
ACE-Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE-inhibitors in the early treatment of acute myocardial infarction: systematic review of individual data from 100,000 patients in randomised trials. Circulation1998; 97: 2202–2212
21.
GrayJ. A question of balance: could integrated care pathways be the answer?Journal of Integrated Care Pathways2001; 5: 141–143
